Below is this week’s congressional update by BakerHostetler’s Federal Policy team. We’ll continue to post in weeks when both chambers of Congress are in session. HEADLINES Congress returns for its lame-duck session, with several uncalled House elections leaving the chamber’s majority in the 118th Congress uncertain. The Republican Party faces a reckoning this week, after … Continue Reading
Below is this week’s congressional update by BakerHostetler’s Federal Policy team. We’ll continue to post in weeks when both chambers of Congress are in session. HEADLINES President Joe Biden will visit Buffalo Tuesday, after 10 people died in a supermarket shooting that local authorities have described as “straight up, a racially motivated hate crime.” Pennsylvania … Continue Reading
By: Adam J. Higgins Below is this week’s congressional update by BakerHostetler’s Federal Policy team. We’ll continue to post in weeks when both chambers of Congress are in session. HEADLINES Congressional Democrats are braced for “a time of intensity” this week as they hope to keep the government open, approve bipartisan infrastructure legislation, and reach … Continue Reading
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. DRUG PRICES: CONGRESS RETURNS, PICKS UP WHERE LAWMAKERS LEFT OFF Congress reconvenes today after a two-week spring recess, with lawmakers in both parties continuing their focus on prescription drug prices. House and Senate committees are planning a … Continue Reading
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. HOUSE PANEL TO VOTE ON BIPARTISAN DRUG PRICING MEASURE The House Ways and Means Committee is scheduled to vote Tuesday on legislation that contains several prescription drug pricing provisions, including requiring pharmacy benefit managers to disclose details … Continue Reading
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. GOTTLIEB, HARGAN TO TESTIFY ON 2020 HEALTH BUDGET, PROGRAMS Outgoing FDA Commissioner Scott Gottlieb and the No. 2 official at HHS will be on Capitol Hill this week testifying on the Trump administration’s proposed budget for fiscal … Continue Reading
Amid finger-pointing but few real fireworks, the seven pharmaceutical executives testifying before the Senate Finance Committee today offered lawmakers a spirited defense of the industry but also substantive policy concessions to address drug prices. They avoided gaffes and left the industry in no worse a political position than before the hearing. Democrats predictably were unsatisfied, … Continue Reading
Senate Democrats recently introduced the Stop Price Gouging Act (S. 378), which seeks to place an excise tax on pharmaceutical companies in proportion to price spikes on prescription drugs. The bill generally requires a company to justify to the Department of Health and Human Services (DHHS) any spike in prescription drug prices, but it is … Continue Reading
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: Trump will discuss healthcare and drug costs in this week’s State of the Union address; Democrats criticize HHS’ drug rebate proposal; dueling hearings highlight the ACA’s pre-existing conditions; House Democrat reveals her cancer is … Continue Reading
Below is the Federal Policy team’s weekly preview, published each week when Congress is in session. HEADLINES • Delayed because of the partial government shutdown, President Donald Trump will deliver the State of the Union address on Tuesday. • Congressional negotiators continue to discuss border security legislation as they seek to avert another government shutdown. … Continue Reading
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: With the shutdown over (for now), the FDA is back in business; two hearings spotlight drug prices; House GOP questions CMS on Medicaid managed care; and more.… Continue Reading
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. We’re posting on Tuesday this week because of the Martin Luther King, Jr. federal holiday. Highlights this week: Gottlieb warns FDA’s funds running low as shutdown continues; House Dems launch sweeping probe on drug prices, Senate approves … Continue Reading
Below is the Federal Policy team’s weekly preview, published each week when Congress is in session. HEADLINES • The 116th Congress convenes for its first full week of session, with no end in sight to a standoff over border wall funding that has shut down about one-quarter of the government since before Christmas. • House … Continue Reading
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: how the partial government shutdown is affecting operations at the FDA; House Democrats take steps to defend the ACA; the House votes this week to renew emergency health response programs; new senators are added … Continue Reading
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: Healthcare legislative priorities are caught up in a separate spending debate that could lead to a partial government shutdown; some GOP lawmakers push back on Trump’s Part B pilot program; a key Democrat says … Continue Reading
Below is the Federal Policy team’s weekly preview, published each week when Congress is in session. HEADLINES • Congress continues its lame-duck session after last week’s Thanksgiving recess and with only eight legislative days ahead before funding for nearly 40 percent of the government expires. • House lawmakers are focused on organizational matters for the … Continue Reading
Below is this week’s “Capitol Hill Healthcare Update,” posted on Mondays when Congress is in session. Featured in this week’s Update, the Senate votes today on opioids legislation (the House is not in session this week); Congress reaches an agreement on fiscal 2019 healthcare funding; the pharma industry last week suffers both a setback and … Continue Reading